Skip to main content

Invus — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

104
Companies
$7.4B
Total invested
$80.3M
Avg. check
36
Industries
Biotechnology 11Health Care 11Medical 6Therapeutics 5Pharmaceutical 5Life Science 4+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 104
Marlette Funding
March 2022

Marlette Funding is a financial tech company tasked to empower customers.

Financial Services · Wilmington$225.0M Series E
ClearScore
February 2025

ClearScore is a fintech company that provides free credit scores, credit reports, and financial product recommendations to consumers.

Analytics · London$38.0M Debt Financing
Mission Lane
February 2024

Mission Lane is a consumer finance company dedicated to helping everyone have access to fair and clear credit.

Credit · RichmondVenture - Series Unknown
NextPoint Therapeutics
February 2024

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Biotechnology · Cambridge$42.5M Series B
Hemab
October 2025

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Biotechnology · Copenhagen$157.0M Series C
Dorsia
February 2025

Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities

Online Portals · Miami Beach$50.4M Series A
Bambusa Therapeutics
February 2025

Bambusa Therapeutics operates as biotechnology company.

Biotechnology · Boston$90.0M Series A
Tasca
December 2024

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

Biopharma · Boston$52.0M Series A
Convergent Therapeutics
September 2024

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Health Care · Cambridge$40.0M Series A
KNIME
August 2024

KNIME provides a platform for end-to-end data science and analytics.

Analytics · Zúrich$30.0M Venture - Series Unknown
Pi Health
March 2024

Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites

Cambridge$30.9M Series A
Tisento Therapeutics
July 2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health Care · Cambridge$81.0M Series A
Presidio Medical
June 2023

Presidio Medical is a medtech company that develops a transformational neuromodulation platform.

Developer Platform · South San Francisco$72.0M Series C
Belliwelli
January 2023

Belliwelli offers four gut-friendly, plant-based snack bars that caters to people with IBS.

Food and Beverage · Los Angeles$15.4M Series A
Foghorn Therapeutics
January 2026

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Biopharma · Cambridge$50.0M Post-IPO Equity
Imvax
January 2025

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

Biotechnology · Philadelphia$29.0M Venture - Series Unknown
Triana Biomedicines
December 2025

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Biopharma · Lexington$120.0M Series B
Lyndra Therapeutics
December 2023

Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.

Biotechnology · Watertown$101.0M Series E
PrognomiQ
January 2026

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

Biopharma · San Mateo$11.9M Venture - Series Unknown
Inotrem
November 2023

Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.

Biotechnology · ParisVenture - Series Unknown
Ablative Solutions
November 2025

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.

Biotechnology · Wakefield$10.4M Venture - Series Unknown
Adevinta
January 2024

Adevinta is a digital marketplace that provides online classifieds services.

Classifieds · OsloPost-IPO Equity
Evenly Technologies, Inc.
January 2022

Evenly is a technology and telemedicine platform that enables general dentists to provide orthodontics in their practice.

Dental · WashingtonSeed
Aive
November 2025

AI video platform for large-scale video automation

Artificial Intelligence (AI) · Levallois-perret$5.2M Series A

Where Invus invests

Biotechnology11
Health Care11
Medical6
Therapeutics5
Pharmaceutical5
Life Science4

About Invus's portfolio

How many companies has Invus invested in?

Invus has invested in 104 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Invus invest in?

Invus's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 36 different industry categories.

What is Invus's largest investment?

Among tracked funding rounds, Marlette Funding received $225.0M in a Series E round. Invus's total known invested capital is $7.4B.

What is the average investment size for Invus?

Invus's average investment size is $80.3M across its portfolio of 104 companies.

What are Invus's most recent investments?

Recent Invus portfolio additions include Marlette Funding, ClearScore, Mission Lane, NextPoint Therapeutics, Hemab. These companies were founded in 2020 or later.

Reach the founders behind these 104 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →